Professor Curtis is a Clinical Haematologist and Director of Malignant Haematology Research at the Australian Centre for Blood Diseases, Monash University, Alfred Hospital. He is a senior bone marrow transplant physician at Alfred Health, where he is leading a national randomised trial of post-transplant cyclophosphamide for the prevention of graft versus host disease, a life-threatening complication following bone marrow transplant. His research focuses on understanding how normal blood stem cells develop into leukaemia and how these abnormal leukaemia stem cells can survive high dose treatments including chemotherapy and bone marrow transplant. Professor Curtis has attracted over $20 million in research funds including funding for National Centre of Research Excellence for Blood and Cell Therapies, with the goal of increasing clinical trials for improving outcomes for patients having bone marrow transplants and training for the next generation of physician scientists.